1-3 of 3
Jeffrey L. Kutok, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Immunotherapy with a CpG Oligonucleotide and Rituximab (R) Augments the Immunological Response and Favorably Alters the Malignant Microenvironment of Follicular Lymphoma (FL).

Jonathan W. Friedberg, MD, MMSc, Jennifer Kelly, MPH, Jeffrey L. Kutok, MD, Rabih Salloum, MD, David C. Fisher, MD, Elizabeth Ronan, Virginia Dalton, RN, Lynn Rich, RN, Diana Marquis, Paul G. Rothberg, MD, Jane Liesveld, MD, Richard I. Fisher, MD, Robert Coffman, PhD, Tim Mosmann, PhD, Arnold S. Freedman, MD
Journal: Blood
Blood (2006) 108 (11): 2713.
https://doi.org/10.1182/blood.V108.11.2713.2713
Published: 2006
Journal Articles

CpG Oligonucleotide (1018 ISS) May Overcome Rituximab (R) Resistance in Follicular Lymphoma (FL) through Enhanced ADCC, T Cell Expansion, and Alteration of Tumor Microenvironment.

Jonathan W. Friedberg, MD, Jennifer Kelly, Jeffrey L. Kutok, MD, Rabih Salloum, MD, Thomas Brenn, MD, David C. Fisher, MD, Elizabeth Ronan, Mary McCauley, RN, Lynn Rich, RN, Diana Marquis, Paul G. Rothberg, PhD, Jane Liesveld, MD, Richard I. Fisher, MD, Robert Coffman, PhD, Tim Mosmann, PhD, Arnold S. Freedman, MD
Journal: Blood
Blood (2005) 106 (11): 2434.
https://doi.org/10.1182/blood.V106.11.2434.2434
Published: 2005
Journal Articles

Identification of ID4 as a Cooperating Second Hit for T Cell Lymphoma Development in PU.1 URE Δ/Δ Mice.

Bronwyn M. Owens, PhD, Li Yu, PhD, Ulrich Steidl, MD, Jeffrey L. Kutok, MD, Linda K. Clayton, PhD, Katharina Wagner, MD, Hiromi Iwasaki, MD, Chunhui Liu, Björn Hackanson, MD, Koichi Akashi, MD, Christoph Plass, PhD, Daniel G. Tenen, MD, Frank Rosenbauer, PhD
Journal: Blood
Blood (2005) 106 (11): 2613.
https://doi.org/10.1182/blood.V106.11.2613.2613
Published: 2005